−1.0370USD
−6.714MUSD
5.448M
About Cadrenal Therapeutics, Inc.
Sector
Industry
CEO
Quang X. Pham
Website
Headquarters
Ponte Vedra Beach
Employees (FY)
3
ISIN
US1276361086
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focused on developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang Pham on January 25, 2022 and is headquartered in Ponte Vedra, FL.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
